The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, foundations, government, not for profit organizations, non-governmental organizations, the private sector, military and private practice.
Symposia
Clinical development of new treatments to support the global elimination of onchocerciasis
Date: Saturday, 20 November 2021
Time: 8:00
Location: National Harbor 10/11 (National Harbor Level)
Symposium organizer: Gary Weil, Washington University School of Medicine
Co-chair: Christy Hanson, Bill & Melinda Gates Foundation
| Clinical trials to test new treatments for onchocerciasis at the University of Health and Allied Sciences in Ghana Nicholas Opoku, School of Public Health University of Health and Allied Sciences (UHAS), University of Health and Allied Sciences |
| Doxycycline and beyond – pros and cons of anti-Wolbachia drugs against onchocerciasis Achim Hoerauf, University of Bonn Medical Center |
| Repurposing and innovative trial designs to evaluate new treatments for onchocerciasis Sabine Specht, Head of Filarial diseases, DNDi |
| Developing moxidectin as a tool for elimination of onchocerciasis: the path to community use Mark Sullivan, Medicines Development for Global Health |
New developments in mycetoma
Date: Friday, 19 November 2021
Time: 13:45
Location: National Harbor 2/3 (National Harbor Level)
Symposium organizer: Eduard Zijlstra, DNDi
Co-chair: Kingsley Asiedu, World Health Organization
| Inhibiting melanin synthesis in mycetoma: a new treatment for mycetoma? Wendy van de Sande, Erasmus MC |
| Exploring the landscape for new treatment in mycetoma Eduard Zijlstra, Expert in PKDL/Mycetoma, DNDi |
| Overview of mycetoma available treatments in endemic areas Maria de Guadalupe Chávez-López, Department of Dermatology and Mycology, Acapulco General Hospital, Health Secretary Guerrero, Community Dermatology Mexico |
| Fungal NTDs – opportunities for integration Roderick Hay, Kings College London |
Posters
| Mass balance, pharmacokinetics and excretion of acoziborole, a potential novel treatment for human African trypanosomiasis, following single oral dose to healthy subjects Gillon JY, Simon F, Sidhu S, Louis M, Launay D, Rembry S, Wauthier V, van Andel L, Loyau S, Tarral A |
| Replacement of missing values for one-time-measurement outcomes in onchocerciasis clinical trials Gruetzmacher B, Specht S, Debrah AY, Schmid M, Hoerauf A, Klarmann-Schulz U |
